Status:
COMPLETED
Therapeutic Effects of Constraint-Induced Movement Therapy on Young Children With Cerebral Palsy
Lead Sponsor:
Samsung Medical Center
Conditions:
Cerebral Palsy Spastic Hemiplegic
Eligibility:
All Genders
7-36 years
Phase:
NA
Brief Summary
This study evaluates the therapeutic effects of constraint-induced movement therapy on infants and children with hemiplegic cerebral palsy. Half of the participants will receive CIMT (constraint-induc...
Detailed Description
This study evaluates the therapeutic effects of constraint-induced movement therapy on infants and children with hemiplegic cerebral palsy. Half of the participants will receive CIMT (constraint-induc...
Eligibility Criteria
Inclusion
- spastic hemiplegic cerebral palsy patients
- 7\~36 months old
Exclusion
- cognitive impairment severe enough to make participation impossible
- uncontrolled epilepsy
- visual or hearing impairment
- musculoskeletal disorders
Key Trial Info
Start Date :
September 14 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 28 2019
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT03858335
Start Date
September 14 2015
End Date
September 28 2019
Last Update
July 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea, 06351